Google
EMBC 株価分析 — EMBECTA CORP (Healthcare >> Medical Instruments & Supplies)
EMBC に関するよくある質問
EMBCのPER（株価収益率）は？
EMBECTA CORP（EMBC）は現在PER 1.94倍で取引されています。
EMBCのROE（自己資本利益率）は？
EMBECTA CORPのROEは-17.87%です。
EMBCの配当利回りは？
EMBECTA CORPの配当利回りは16.30%です。
EMBCの品質スコア（Quality Score）は？
当社のAIはEMBCの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
EMBCは今が買い時ですか？
当社AIのタイミングスコアは100点中51点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
EMBCはどのセクターに属しますか？
EMBECTA CORPはHealthcare >> Medical Instruments & Suppliesセクターに分類されます（NASDAQ市場）
EMBC AI Analysis Summary
Our AI summary for EMBC: EMBECTA CORP (NASDAQ), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 1.94, ROE of -17.87%, a dividend yield of 16.30%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 51/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 3.64
Price
-0.02
(-0.55%)
Day Change
|
|
|---|
EMBC, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 40 |
| Magic Formula Rank by ROA |
179
|
| Magic Formula Rank by ROE |
179
|
| Magic Formula Rank by ROIC |
82
GOOD
|
| Price | 3.64 |
| PBV / Sector |
-0.35 / 3.37
|
| Earning Per Share | 1.88 |
| PE / Sector |
1.94 / 44.25
GREAT
|
| PEG or PE/Growth / Sector |
-0.15 / -1.35
|
| Average 1M Daily Value |
4.27 M
GREAT
|
| Average 1W Daily Value |
3.84 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
66% |
| 配当 |
|
100% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:46 |
| Symbol | EMBC |
| Name | EMBECTA CORP |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NASDAQ |
| Listed Shares | 59.33 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 217.14 / 16,159.14 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 300 Kimball Drive, Parsippany, NJ, United States, 07054
Phone: 862 401 0000
Website: https://www.embecta.com
Employees: 1,850
Description: Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
